Literature DB >> 11512557

Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadian and Yemenite Jewish hereditary breast cancer families.

A P Manning1, D Abelovich, P Ghadirian, J A Lambert, D Frappier, D Provencher, A Robidoux, T Peretz, S A Narod, A M Mes-Masson, W D Foulkes, T Wang, K Morgan, T M Fujiwara, P N Tonin.   

Abstract

The BRCA2 8765delAG mutation was previously reported in hereditary breast cancer families of French Canadian and Yemenite Jewish descent. Haplotype analysis, using six microsatellite markers that span BRCA2 and two intragenic polymorphisms, was performed on 8765delAG mutation carriers to determine if there was evidence that the mutations were identical by descent. The alleles of the microsatellite markers most closely flanking BRCA2 (D13S1697 and D13S1701) were found to be identical in state in all the mutation carriers. However, the disease-associated allele of one of the intragenic markers differed between the Yemenite Jews and French Canadian families, indicating that the 8765delAG mutation has independent origins in these two geographically and ethnically distinct populations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11512557     DOI: 10.1159/000053364

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  12 in total

1.  The Tyr978X BRCA1 mutation: occurrence in non-Jewish Iranians and haplotype in French-Canadian and non-Ashkenazi Jews.

Authors:  Lluís Quintana-Murci; Inbar Gal; Tangiz Bakhan; Hélène Quach; S Hamid Sayar; Ronit Shiri-Sverdlov; Ruth Gershoni Baruch; Ken McElreavey; Efrat Dagan; Steven Narod; Eitan Friedman
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

2.  Comprehensive BRCA1 and BRCA2 mutation analyses and review of French Canadian families with at least three cases of breast cancer.

Authors:  Luca Cavallone; Suzanna L Arcand; Christine M Maugard; Serge Nolet; Louis A Gaboury; Anne-Marie Mes-Masson; Parviz Ghadirian; Diane Provencher; Patricia N Tonin
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

3.  The 1100delAT BRCA1 and the 8765delAG BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews and haplotype comparison of Jewish and non-Jewish carriers.

Authors:  Inbar Gal; Ruth Gershoni Baruch; Daniel Haber; Efrat Dagan; Shlomit Eisenberg-Barzilai; Jamal Zidan; Eitan Friedman
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

4.  A review of histopathological subtypes of ovarian cancer in BRCA-related French Canadian cancer families.

Authors:  Patricia N Tonin; Christine M Maugard; Chantal Perret; Anne-Marie Mes-Masson; Diane M Provencher
Journal:  Fam Cancer       Date:  2007-07-17       Impact factor: 2.375

5.  Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families.

Authors:  Kathleen K Oros; Guy Leblanc; Suzanna L Arcand; Zhen Shen; Chantal Perret; Anne-Marie Mes-Masson; William D Foulkes; Parviz Ghadirian; Diane Provencher; Patricia N Tonin
Journal:  BMC Med Genet       Date:  2006-03-15       Impact factor: 2.103

6.  The frequent BRCA1 mutation 1135insA has multiple origins: a haplotype study in different populations.

Authors:  Teresa M Rudkin; Nancy Hamel; Maria Galvez; Frans Hogervorst; Johan J P Gille; Pål Møller; Jaran Apold; William D Foulkes
Journal:  BMC Med Genet       Date:  2006-03-01       Impact factor: 2.103

7.  A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population.

Authors:  Moria H Belanger; Lena Dolman; Suzanna L Arcand; Zhen Shen; George Chong; Anne-Marie Mes-Masson; Diane Provencher; Patricia N Tonin
Journal:  J Ovarian Res       Date:  2015-03-27       Impact factor: 4.234

8.  Contribution of the PALB2 c.2323C>T [p.Q775X] founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent.

Authors:  Marc Tischkowitz; Nelly Sabbaghian; Nancy Hamel; Carly Pouchet; William D Foulkes; Anne-Marie Mes-Masson; Diane M Provencher; Patricia N Tonin
Journal:  BMC Med Genet       Date:  2013-01-09       Impact factor: 2.103

9.  Origin and distribution of the BRCA2-8765delAG mutation in breast cancer.

Authors:  Grazia Palomba; Antonio Cossu; Eitan Friedman; Mario Budroni; Antonio Farris; Antonio Contu; Marina Pisano; Paola Baldinu; Maria C Sini; Francesco Tanda; Giuseppe Palmieri
Journal:  BMC Cancer       Date:  2007-07-19       Impact factor: 4.430

10.  Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent.

Authors:  Luca Cavallone; Suzanna L Arcand; Christine Maugard; Parviz Ghadirian; Anne-Marie Mes-Masson; Diane Provencher; Patricia N Tonin
Journal:  BMC Cancer       Date:  2008-04-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.